NO950610L - Fremgangsmåte for ödeleggelse eller inhibering av vekst av uönskede celler eller vev - Google Patents

Fremgangsmåte for ödeleggelse eller inhibering av vekst av uönskede celler eller vev

Info

Publication number
NO950610L
NO950610L NO950610A NO950610A NO950610L NO 950610 L NO950610 L NO 950610L NO 950610 A NO950610 A NO 950610A NO 950610 A NO950610 A NO 950610A NO 950610 L NO950610 L NO 950610L
Authority
NO
Norway
Prior art keywords
destroying
tissues
inhibiting
growth
unwanted cells
Prior art date
Application number
NO950610A
Other languages
English (en)
Other versions
NO950610D0 (no
Inventor
Anna Richter
Julia G Levy
David Dolphin
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of NO950610D0 publication Critical patent/NO950610D0/no
Publication of NO950610L publication Critical patent/NO950610L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO950610A 1992-08-17 1995-02-17 Fremgangsmåte for ödeleggelse eller inhibering av vekst av uönskede celler eller vev NO950610L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93016592A 1992-08-17 1992-08-17
PCT/CA1993/000328 WO1994004147A1 (en) 1992-08-17 1993-08-17 Method for destroying or inhibiting growth of unwanted cells or tissues
CN93116757A CN1099612A (zh) 1992-08-17 1993-09-03 破坏或抑制不需要的细胞或组织生长的方法

Publications (2)

Publication Number Publication Date
NO950610D0 NO950610D0 (no) 1995-02-17
NO950610L true NO950610L (no) 1995-03-16

Family

ID=36869960

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950610A NO950610L (no) 1992-08-17 1995-02-17 Fremgangsmåte for ödeleggelse eller inhibering av vekst av uönskede celler eller vev

Country Status (9)

Country Link
US (1) US5945439A (no)
EP (1) EP0654993A1 (no)
JP (1) JPH08505361A (no)
CN (1) CN1099612A (no)
AU (1) AU4695493A (no)
CA (1) CA2142711A1 (no)
FI (1) FI950730L (no)
NO (1) NO950610L (no)
WO (1) WO1994004147A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693789A (en) * 1996-04-10 1997-12-02 Abbott Laboratories Process for the preparation of a protoporphyrin
CA2206203A1 (en) * 1997-05-27 1998-11-27 University Of British Columbia Photoactivation of endogenous porphyrins for treatment of psoriasis
WO2000021965A1 (en) 1998-10-13 2000-04-20 Brown University Research Foundation Substituted perhalogenated phthalocyanines
CA2395567A1 (en) * 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
DE10020935A1 (de) * 2000-04-28 2001-11-08 Alfons Hofstetter Verwendung von Photofrin als Radiosensitizer
AU2002233092A1 (en) 2001-02-15 2002-08-28 Qlt Inc. Reduction or prevention of pdt related inflammation
US7041046B2 (en) * 2001-05-07 2006-05-09 Xoft, Inc. Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasia
JP2005513001A (ja) * 2001-11-09 2005-05-12 キュー エル ティー インク． 脱毛治療のための光力学療法
ATE336266T1 (de) * 2002-06-21 2006-09-15 Adair Edwin Lloyd Anwendung von metalloporphyrinen zur behandlung von arteriosklerose
US20040110731A1 (en) * 2002-12-04 2004-06-10 Chan Agnes H. Photodynamic therapy for the treatment of non-melanoma skin cancer
EP1771205B1 (en) 2004-06-18 2016-10-26 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
EP1818723B1 (en) * 2004-12-03 2011-05-04 JSR Corporation Composition for forming antireflection film, layered product, and method of forming resist pattern
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US20070299431A1 (en) * 2006-05-02 2007-12-27 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
CA2699394C (en) 2007-09-17 2020-03-24 The Regents Of The University Of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
US10029115B2 (en) * 2011-04-08 2018-07-24 Sanovas Intellectual Property, Llc Photodynamic therapy for tumors with localized delivery
EP3383920B1 (en) 2015-11-30 2024-01-10 The Regents of the University of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
KR102775461B1 (ko) 2016-04-01 2025-02-28 어비디티 바이오사이언시스 인크. 핵산-폴리펩타이드 조성물 및 이의 용도
EP3538551A4 (en) 2016-11-10 2020-11-11 Fortis Therapeutics, Inc. CD46 SPECIFIC EFFECTOR CELLS AND USES THEREOF
US11434301B2 (en) 2016-11-11 2022-09-06 The Regents Of The University Of California Anti-CD46 antibodies and methods of use
CN113302207B (zh) 2018-11-16 2025-05-13 维尔托索宾科公司 Cd38和icam1抗体及其用途
IL312067B2 (en) 2018-12-21 2025-08-01 Avidity Biosciences Inc Anti-transferrin receptor antibodies and uses thereof
TW202144572A (zh) 2020-03-19 2021-12-01 美商亞維代堤生物科學公司 治療臉肩胛肱骨肌肉失養症之組合物及方法
KR102927945B1 (ko) 2020-03-27 2026-02-23 어비디티 바이오사이언시스 인크. 근이영양증의 치료용 조성물 및 방법
JP2023534765A (ja) 2020-08-07 2023-08-10 フォーティス セラピューティクス，インク． 免疫複合体を標的とするｃｄ４６およびその使用方法
EP4401792A4 (en) 2021-09-16 2025-12-03 Avidity Biosciences Inc COMPOSITIONS AND METHODS OF TREATMENT OF FACIO-SCAPULO-HUMERAL MUSCULAR DYSTROPHY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5091385A (en) * 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds

Also Published As

Publication number Publication date
NO950610D0 (no) 1995-02-17
CA2142711A1 (en) 1994-03-03
FI950730A7 (fi) 1995-04-10
FI950730A0 (fi) 1995-02-17
US5945439A (en) 1999-08-31
JPH08505361A (ja) 1996-06-11
EP0654993A1 (en) 1995-05-31
AU4695493A (en) 1994-03-15
FI950730L (fi) 1995-04-10
CN1099612A (zh) 1995-03-08
WO1994004147A1 (en) 1994-03-03

Similar Documents

Publication Publication Date Title
NO950610D0 (no) Fremgangsmåte for ödeleggelse eller inhibering av vekst av uönskede celler eller vev
FI905228A0 (fi) Menetelmä mikro-organismien kasvun ja lisääntymisen ehkäisemiseksi
NO944919D0 (no) Fremgangsmåte for å inhibere atrofi av huden eller vagina
NO970156D0 (no) Fremgangsmåte ved inhibering av vekst av celler innkapslet i kunstige organer
DE3165507D1 (en) 5-alkylsalicylanilides derivatives and method for inhibiting the growth of microorganisms
ES557848A0 (es) Metodo de controlar insectos e inhibir su crecimiento.
DE59209679D1 (de) Implantat zur elektrischen Impulsbeaufschlagung von lebendem Gewebe
DE69429336D1 (de) Zusammensetzung von Pflanzenwachstums-Beschleuniger
FI871918A7 (fi) Koostumus ja menetelmä mikrobikasvun estämiseksi.
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
BR8804434A (pt) Composicao de revestimento eletrodeponivel catodica e metodo de revestimento
DK649689D0 (da) Fremgangsmaade til eliminering eller inhibering af vaeksten af uoenskede mikroorganismer
FI891813L (fi) Mikro-organismeja tappava/mikro-organismien kasvua estävä koostumus teollista käyttöä varten sekä menetelmä mikro-organismien tappamiseksi tai niiden kasvun estämiseksi
AU6728690A (en) Method for inhibiting the growth of salmonella
FI922780A7 (fi) Siementen päällyste ja menetelmä siementen päällystämiseksi
AU6125890A (en) Method and composition for destroying or inhibiting growth of microorganisms
DE69313595D1 (de) Verfahren zur Herstellung von Isopropylacetat
IT8568064A0 (it) Procedimento per la rimozione dai tessuti di contaminanti vegetali edi altri contaminanti cellulosici
AU2847089A (en) Cathodic protection method and compositions
HUT37154A (en) Biocide agents and method for the extermination of the pests
DE69408394D1 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
DE69424475D1 (de) Verfahren zur Herstellung von 1-(2'-deoxy-beta-D-erythropentofuranosyl)-5-trifluormethyluracil Derivaten
IT8747655A0 (it) Metodo e composizione per migliorare il regime di crescita di animali
AU639964B2 (en) Method and means for the management of trees or other plants
GB8923367D0 (en) Method and composition for preventing or inhibiting plant virus diseases